Search results
Home Phototherapy for Psoriasis: Optimizing Access
Medscape· 4 days agoSupporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of...
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 3 days agoThe randomised, global, double-blind, vehicle-controlled, dose-ranging trial is designed to assess...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 5 days agoThe board will seek public comments, additional information and data over the next 60 days to...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 5 days agoTremfya is an interleukin (IL)-23 and CD64-inhibiting monoclonal antibody. It was first approved as...
Ultravate side effects: What they are and how to manage them
Healthline· 6 days agoUltravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that ...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 5 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 1 day agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 6 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 4 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 5 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...